Comparison of four methodologies for rapid and cost-effective identification of Candida glabrata

Journal of Clinical Microbiology

Volumn 37, Issue 10, 1999, Pages 3387-3389

  Fenn, JoAnn P ^b   Billetdeaux, Erick ^a   Segal, Helene ^a   Skodack Jones, Lisa ^a   Padilla, Pamela E ^b   Bale, Martha ^a   Carroll, Karen ^a,b  

^a ARUP LABORATORIES   (United States)

^b UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TREHALOSE;

ARTICLE; CANDIDA GLABRATA; CONTROLLED STUDY; COST EFFECTIVENESS ANALYSIS; FERMENTATION; NONHUMAN; PRIORITY JOURNAL; SCREENING TEST; TURNOVER TIME;

CANDIDA GLABRATA;

EID: 0032851207     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/jcm.37.10.3387-3389.1999     Document Type: Article

References (14)

1. Fenn, J. P., H. Segal, B. Barland, D. Denton, J. Whisenant, H. Chun, K. Christofferson, L. Hamilton, and K. Carroll. 1994. Comparison of updated Vitek Yeast Biochemical Card and API 20C yeast identification systems. J. Clin. Microbiol. 32:1184-1187.
2. Fidel, P. L., Jr., J. A. Vazquez, and J. D. Sobel. 1999. Candida glabrata: review of epidemiology, pathogenesis, and clinical disease with comparison to Candida albicans. Clin. Microbiol. Rev. 12:80-96.
3. Glick, C., G. R. Graves, and S. Feldman. 1993. Torulopsis glabrata in the neonate: an emerging fungal pathogen. S. Med. J. 86:969-970.
4. Hitchcock, C. A., G. W. Pye, P. F. Troke, E. M. Johnson, and D. W. Warnock. 1993. Fluconazole resistance in Candida glabrata. Antimicrob. Agents Chemother. 37:1962-1965.
5. Komshian, S. V., A. K. Uwaydah, J. D. Sobel, and L. R. Crane. 1989. Fungemia caused by Candida species and Torulopsis glabrata in the hospitalized patient: frequency, characteristics, and evaluation of factors influencing outcome. Rev. Infect. Dis. 11:379-390.
6. Kwon-Chung, K. J., and J. E. Bennett. 1992. Medical mycology, p. 62. Lea & Febiger, Malvern, Pa.
7. Land, G., J. Burke, C. Shelbj, J. Rhodes, J. Collett, I. Bennett, and J. Johnson. 1996. Screening protocol for Torulopsis (Candida) glabrata. J. Clin. Microbiol. 34:2300-2303.
8. Mayo Clinic. 1997. Mycology laboratory procedure manual, p. 71-73. Division of Clinical Microbiology, Mayo Clinic, Rochester, Minn.
9. Peltroche-Llacsahuanga, H., N. Schnitzler, R. Lutticken, and G. Haase. 1999. Rapid identification of Candida glabrata by using a dipstick to detect trehalose-generated glucose. J. Clin. Microbiol. 37:202-205.
10. Redondo-Lopez, V., M. Lynch, C. Schmitt, R. Cook, and J. D. Sobel. 1990. Torulopsis glabrata vaginitis: clinical aspects and susceptibility to antifungal agents. Obstet. Gynecol. 76:651-655.
11. Rex, J. H., M. G. Rinaldi, and M. A. Pfaller. 1995. Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 39:1-8.
12. Stockman, L., and G. Roberts. 1985. Rapid screening method for the identification of C. glabrata, abstr. F-80, p. 377. In Abstracts of the 85th Annual Meeting of the American Society for Microbiology 1985. American Society for Microbiology, Washington, D.C.
13. Vasquez, J. A., L. M. Dembry, B. Sanchez, M. A. Vasquez, J. D. Sobel, C. Dmuchowske, and M. J. Zervos. 1998. Nosocomial Candida glabrata colonization: an epidemiologic study. J. Clin. Microbiol. 36:421-426.
14. White, D. J., E. M. Johnson, and D. W. Warnock. 1993. Management of persistent vulvo vaginal candidosis due to azole-resistant Candida glabrata. Genitourin. Med. 69:112-114.